Neuphoria Therapeutics Inc. (NEUP) quarterly income statement — complete revenue, gross profit & net income history
Neuphoria Therapeutics Inc. (NEUP) annual income statement — 28-year revenue, gross profit & net income history
| Metric | Q1'27 | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|
| Sales/Revenue | 0 | 1.17M | 0 | 0 | 0 | -10.47M | 15M | 662.72K | 10.05M | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | 111.21% | -100% | -100% | -100% | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 165.68K | 165.69K | 165.79K | 165.79K | 331.14K | 165.43K | 2.81M | 165.71K | 165.69K | 255.18K | 0 | 0 |
| COGS % of Revenue | - | 14.11% | - | - | - | -3.16% | 1.1% | 423.49% | 1.65% | - | - | - | - |
| Gross Profit | 0 | 1.01M | -165.69K | -165.79K | -165.79K | -10.47M | 15M | 662.72K | -165.71K | -165.69K | -255.18K | 0 | 0 |
| Gross Margin % | - | 85.89% | - | - | - | 100% | 100% | 100% | -1.65% | - | - | - | - |
| Gross Profit Growth % | 100% | 109.63% | -101.1% | -125.02% | -0.05% | -6220.7% | 5978.32% | - | - | - | - | - | - |
| Operating Expenses | 2.23M | 1.17M | 1M | 4.06M | 5.65M | 16.77B | 3.03M | 4.37M | 3.4M | 5.48M | 3.69M | 6.67M | 8.54M |
| OpEx % of Revenue | - | 99.85% | - | - | - | -160111.44% | 20.19% | 658.84% | 33.85% | - | - | - | - |
| Selling, General & Admin | 2.1M | 1.17M | 2.45M | 3.19M | 2.82M | -1.28M | 1.41M | 4.25M | 2.45M | 3.57M | 2.84M | 3.69M | 3.72M |
| SG&A % of Revenue | - | 99.85% | - | - | - | 12.2% | 9.38% | 640.87% | 24.42% | - | - | - | - |
| Research & Development | 132.01K | 0 | -752.55K | 1.05M | 5.73M | 700.57K | 1.62M | 2.81M | 2.8M | 4.64M | 2.84M | 2.98M | 4.82M |
| R&D % of Revenue | - | - | - | - | - | -6.69% | 10.77% | 423.41% | 27.85% | - | - | - | - |
| Other Operating Expenses | 0 | 0 | -694.58K | -170.78K | -1000K | 1000K | 5.23K | -1000K | -1000K | -1000K | -1000K | 0 | 0 |
| Operating Income | -2.1M | -163.91K | -1.17M | -4.06M | -8.55M | -10.38M | 11.97M | 2.53M | -3.57M | -8.2M | -5.68M | -6.67M | -8.54M |
| Operating Margin % | - | -13.96% | - | - | - | 99.13% | 79.81% | 382.42% | -35.49% | - | - | - | - |
| Operating Income Growth % | 75.5% | 98.42% | -109.77% | -260.23% | -139.7% | -26.59% | 310.87% | 137.98% | 58.22% | - | - | - | - |
| EBITDA | -2.1M | 1.76K | -1M | -3.9M | -8.39M | -10.22M | 12.14M | 2.7M | -3.4M | -8.03M | -5.42M | -6.43M | -8.28M |
| EBITDA Margin % | - | 0.15% | - | - | - | 97.59% | 80.92% | 407.49% | -33.85% | - | - | - | - |
| EBITDA Growth % | 75.01% | 100.02% | -108.27% | -244.23% | -146.51% | -27.19% | 323.81% | 142% | 58.91% | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 165.68K | 165.69K | 165.79K | 165.79K | 161.31K | 165.43K | 166.12K | 165.71K | 165.69K | 254.43K | 242.82K | 259.12K |
| EBIT | 0 | -163.91K | -1.17M | -3.51M | -8.55M | -10.38M | 11.97M | 2.53M | -5.25M | -8.2M | -5.68M | -6.53M | -8.54M |
| Net Interest Income | 0 | 170.09K | 186.17K | 167.31K | 142K | 87.05K | 12.74K | 30.61K | 36.1K | 26.33K | 81.03K | 54.72K | 86.44K |
| Interest Income | 0 | 170.09K | 186.17K | 167.31K | 142K | 87.05K | 12.74K | 30.61K | 36.1K | 26.33K | 81.03K | 54.72K | 86.44K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 635.48K | -4.78M | 629.38K | 5.89M | -6.49M | -4.63M | -790.99K | 1.77M | 2.63M | 2.76M | -872.07K | -53.28K | -62.09K |
| Pretax Income | -1.46M | -4.94M | -539.86K | 1.83M | -15.04M | -15.01M | 11.18M | -1.93M | -936.97K | 14.26M | -6.55M | -6.73M | -8.6M |
| Pretax Margin % | - | -420.66% | - | - | - | 143.34% | 74.54% | -291.49% | -9.32% | - | - | - | - |
| Income Tax | -34.79K | -34.79K | -34.79K | -34.79K | -52.64K | -156.85K | -81.19K | 11.61K | -132.19K | 34.12K | 38.85K | -50.99K | -54.34K |
| Effective Tax Rate % | 2.38% | 0.7% | 6.44% | -1.9% | 0.35% | 1.04% | -0.73% | -0.6% | 14.11% | 0.24% | -0.59% | 0.76% | 0.63% |
| Net Income | -1.43M | -4.9M | -505.06K | 1.86M | -14.99M | -14.85M | 11.26M | -1.94M | -804.79K | -2.69M | 11.66M | -6.67M | -8.55M |
| Net Margin % | - | -417.7% | - | - | - | 141.84% | 75.08% | -293.24% | -8.01% | - | - | - | - |
| Net Income Growth % | 90.49% | 66.98% | -104.48% | 195.92% | -1762.3% | -452.8% | -3.42% | 70.88% | 90.58% | - | - | - | - |
| Net Income (Continuing) | -1.43M | -4.9M | -505.06K | 1.86M | -14.99M | -14.85M | 11.26M | -1.94M | -804.79K | -2.69M | 11.66M | -6.67M | -8.55M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.26 | -0.91 | -0.09 | 0.41 | -6.67 | -4.65 | 6.55 | -0.01 | -0.00 | -0.00 | -0.03 | -0.03 | -0.04 |
| EPS Growth % | 96.1% | 80.43% | -101.42% | - | - | - | 22006.35% | 75% | 92.26% | - | - | - | - |
| EPS (Basic) | -0.26 | -0.91 | -0.09 | 0.41 | -6.67 | -4.65 | 6.55 | -0.01 | -0.00 | -0.00 | -0.03 | -0.03 | -0.04 |
| Diluted Shares Outstanding | 5.41M | 5.41M | 5.41M | 4.54M | 2.25M | 1.62M | 234.01M | 234.01M | 234.01M | 92M | 143.52M | 137.23M | 124.67M |
| Basic Shares Outstanding | 5.41M | 5.41M | 5.41M | 4.54M | 2.25M | 1.62M | 234.01M | 234.01M | 234.01M | 92M | 143.52M | 137.23M | 124.67M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - |